BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2666908)

  • 1. N-ras dependent revertant phenotype in human HT1080 fibrosarcoma cells is associated with loss of proliferation within normal tissues and expression of an adult membrane antigenic phenotype.
    Carloni G; Paterson H; Mareel M; Augery-Bourget Y; Sahraoui J; Rubinstein E; Suarez H; Azzarone B
    Oncogene; 1989 Jul; 4(7):873-80. PubMed ID: 2666908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency.
    Benedict WF; Weissman BE; Mark C; Stanbridge EJ
    Cancer Res; 1984 Aug; 44(8):3471-9. PubMed ID: 6744274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoelectron microscopic localization of the p21 protein in HT1080 human fibrosarcoma cell lines with altered N-ras gene expression.
    Tímár J; Paterson H
    Acta Microbiol Hung; 1991; 39(4):259-65. PubMed ID: 1844332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines.
    Slovak ML; Ho JP; Bhardwaj G; Kurz EU; Deeley RG; Cole SP
    Cancer Res; 1993 Jul; 53(14):3221-5. PubMed ID: 8391919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoelectron microscopic localization of the p21 protein in HT1080 human fibrosarcoma cell lines with altered N-ras gene expression.
    Tímár J; Paterson H
    Acta Morphol Hung; 1991; 39(4):259-65. PubMed ID: 1844338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 6 integrin is up-regulated in step increments accompanying neoplastic transformation and tumorigenic conversion of human fibroblasts.
    Lin CS; Zhang K; Kramer R
    Cancer Res; 1993 Jul; 53(13):2950-3. PubMed ID: 7686445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal adhesion kinase regulates syndecan-2-mediated tumorigenic activity of HT1080 fibrosarcoma cells.
    Park H; Han I; Kwon HJ; Oh ES
    Cancer Res; 2005 Nov; 65(21):9899-905. PubMed ID: 16267014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta 1 selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed fibrosarcoma cell lines.
    Hurta RA; Greenberg AH; Wright JA
    J Cell Physiol; 1993 Aug; 156(2):272-9. PubMed ID: 8344985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells.
    Paterson H; Reeves B; Brown R; Hall A; Furth M; Bos J; Jones P; Marshall C
    Cell; 1987 Dec; 51(5):803-12. PubMed ID: 3315232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasion of tumorigenic HT1080 cells is impeded by blocking or downregulating the 37-kDa/67-kDa laminin receptor.
    Zuber C; Knackmuss S; Zemora G; Reusch U; Vlasova E; Diehl D; Mick V; Hoffmann K; Nikles D; Fröhlich T; Arnold GJ; Brenig B; Wolf E; Lahm H; Little M; Weiss S
    J Mol Biol; 2008 May; 378(3):530-9. PubMed ID: 18387633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ral promotes anchorage-independent growth of a human fibrosarcoma, HT1080.
    Yamazaki Y; Kaziro Y; Koide H
    Biochem Biophys Res Commun; 2001 Jan; 280(3):868-73. PubMed ID: 11162603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
    Park HJ; Lee HJ; Min HY; Chung HJ; Suh ME; Park-Choo HY; Kim C; Kim HJ; Seo EK; Lee SK
    Eur J Pharmacol; 2005 Dec; 527(1-3):31-6. PubMed ID: 16309669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of interleukin 1 alpha, interleukin 6, and tumor necrosis factor alpha genes in human melanoma clones is associated with that of mutated N-RAS oncogene.
    Castelli C; Sensi M; Lupetti R; Mortarini R; Panceri P; Anichini A; Parmiani G
    Cancer Res; 1994 Sep; 54(17):4785-90. PubMed ID: 8062279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside 20(S)-protopanaxadiol inhibits the proliferation and invasion of human fibrosarcoma HT1080 cells.
    Li G; Wang Z; Sun Y; Liu K; Wang Z
    Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):588-92. PubMed ID: 16700822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors.
    Alexander JP; Kudoh S; Melsop KA; Hamilton TA; Edinger MG; Tubbs RR; Sica D; Tuason L; Klein E; Bukowski RM
    Cancer Res; 1993 Mar; 53(6):1380-7. PubMed ID: 8443817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy.
    Lorence RM; Katubig BB; Reichard KW; Reyes HM; Phuangsab A; Sassetti MD; Walter RJ; Peeples ME
    Cancer Res; 1994 Dec; 54(23):6017-21. PubMed ID: 7954437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on reversion of the human activated c-Ha-ras-transformed cells].
    Ogiso Y
    Hokkaido Igaku Zasshi; 1988 Sep; 63(5):687-97. PubMed ID: 3071518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfection of normal and transformed hamster cerebral cortex glial cells with activated c-H-ras-1 results in the acquisition of a diffusely invasive phenotype.
    Fetherston JD; Cotton JP; Walsh JW; Zimmer SG
    Oncogene Res; 1989; 5(1):25-30. PubMed ID: 2674858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
    J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of DA-125, a new anthracyclin analog antitumor agent, on the invasion of human fibrosarcoma cells by down-regulating the matrix metalloproteinases.
    Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Kim WB; Kim SH; Lee SK
    Biochem Pharmacol; 2005 Dec; 71(1-2):21-31. PubMed ID: 16271263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.